Zymeworks Inc
NASDAQ:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NASDAQ:ZYME
Watchlist
Price: 13.7 USD -1.23% Market Closed
Market Cap: 973.4m USD
Have any thoughts about
Zymeworks Inc?
Write Note

Zymeworks Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zymeworks Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NASDAQ:ZYME
Operating Expenses
-$182.7m
CAGR 3-Years
9%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$20.6B
CAGR 3-Years
-3%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$11.2B
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$13.3B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.7B
CAGR 3-Years
-10%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.5B
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
-18%

See Also

What is Zymeworks Inc's Operating Expenses?
Operating Expenses
-182.7m USD

Based on the financial report for Jun 30, 2024, Zymeworks Inc's Operating Expenses amounts to -182.7m USD.

What is Zymeworks Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-12%

Over the last year, the Operating Expenses growth was 30%. The average annual Operating Expenses growth rates for Zymeworks Inc have been 9% over the past three years , -12% over the past five years .

Back to Top